The way we test medicines is rigorous but slow. Carrie Arnold investigates the controversial new kinds of clinical trial that promise faster results [ABSTRACT FROM AUTHOR]
Copyright of New Scientist is the property of New Scientist Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.